Madrigal Pharmaceuticals, Inc. (MDGL)

Trade MDGL now with
7/11/2019 7:21:56 AM Madrigal Pharma Promotes Rebecca Taub To Newly Created Position Of President Of Research & Development
7/2/2019 6:59:36 AM Madrigal Names Jim Daly To Board
11/6/2018 6:51:43 AM Madrigal Pharmaceuticals Q3 Loss Per Share $0.56 Vs Loss $0.68 Prior Year
8/7/2018 6:57:49 AM Madrigal Pharma Q2 Net Loss $6.46 Mln Or $0.45/Shr Vs Loss $8.35 Mln Or $0.69/Shr Last Year
6/6/2018 11:35:23 PM Madrigal Pharma Prices Public Offering Of 1.35 Mln Shares At $305.00/shr
6/5/2018 4:12:02 PM Madrigal Pharmaceuticals Announces Proposed Public Offering Of Common Stock
5/31/2018 7:13:05 AM Madrigal’s MGL-3196 Achieves Liver Biopsy Endpoints In Patients With NASH At 36 Weeks In Phase 2 Clinical Trial
5/8/2018 6:51:52 AM Madrigal Pharma Q1 Loss Per Share $0.45 Vs Loss $0.50 Last Year
3/13/2018 6:51:54 AM Madrigal Pharma Q4 Loss Per Share $0.67, Flat With Last Year
2/8/2018 6:52:19 AM Madrigal’s MGL-3196 Achieves Primary Endpoint In Patients With Heterozygous Familial Hypercholesterolemia